BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17976831)

  • 1. Recovery of DNA for the detection and genotyping of human papillomavirus from clinical cervical specimens stored for up to 2 years in a universal collection medium with denaturing reagent.
    Campos EA; Simões JA; Rabelo-Santos SH; Sarian LO; Pitta DR; Levi JE; Derchain S
    J Virol Methods; 2008 Feb; 147(2):333-7. PubMed ID: 17976831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA recovery from Hybrid Capture II samples stored in specimen transport medium with denaturing reagent, for the detection of human papillomavirus by PCR.
    Rabelo-Santos SH; Levi JE; Derchain SF; Sarian LO; Zeferino LC; Messias S; Moraes DL; Campos EA; Syrjänen KJ
    J Virol Methods; 2005 Jun; 126(1-2):197-201. PubMed ID: 15847937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.
    Belinson JL; Hu S; Niyazi M; Pretorius RG; Wang H; Wen C; Smith JS; Li J; Taddeo FJ; Burchette RJ; Qiao YL
    Int J Cancer; 2010 Sep; 127(5):1151-7. PubMed ID: 20039323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two PCR-based human papillomavirus genotyping methods.
    Castle PE; Porras C; Quint WG; Rodriguez AC; Schiffman M; Gravitt PE; González P; Katki HA; Silva S; Freer E; Van Doorn LJ; Jiménez S; Herrero R; Hildesheim A;
    J Clin Microbiol; 2008 Oct; 46(10):3437-45. PubMed ID: 18716224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology.
    Daponte A; Pournaras S; Mademtzis I; Hadjichristodoulou C; Kostopoulou E; Maniatis AN; Messinis IE
    J Clin Virol; 2006 Jul; 36(3):189-93. PubMed ID: 16690350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease.
    Carozzi F; Bisanzi S; Sani C; Zappa M; Cecchini S; Ciatto S; Confortini M
    J Clin Microbiol; 2007 Feb; 45(2):364-9. PubMed ID: 17122008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.
    Sandri MT; Lentati P; Benini E; Dell'Orto P; Zorzino L; Carozzi FM; Maisonneuve P; Passerini R; Salvatici M; Casadio C; Boveri S; Sideri M
    J Clin Microbiol; 2006 Jun; 44(6):2141-6. PubMed ID: 16757611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and genotyping of human papillomavirus (HPV) using PCR-LIS-SSCP].
    Gomez MA; Abba MC; Golijow CD
    Rev Argent Microbiol; 2001; 33(1):22-7. PubMed ID: 11407017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of HPV Linear Array Assay for multiple HPV typing on archival frozen tissue and DNA specimens.
    Woo YL; Damay I; Stanley M; Crawford R; Sterling J
    J Virol Methods; 2007 Jun; 142(1-2):226-30. PubMed ID: 17320976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay.
    Wong AK; Chan RC; Nichols WS; Bose S
    J Clin Microbiol; 2008 Mar; 46(3):869-75. PubMed ID: 18174309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a multiplex PCR to cervical cells collected by a paper smear for the simultaneous detection of all mucosal human papillomaviruses (HPVs) and typing of high-risk HPV types 16 and 18.
    Shukla S; Bharti AC; Mahata S; Hussain S; Hedau S; Sharma R; Pillai MR; Krishna S; Chiplunkar S; Tongaonkar H; Das BC
    J Med Microbiol; 2010 Nov; 59(Pt 11):1303-1310. PubMed ID: 20688948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
    Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
    J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of cervical cytology and human papillomavirus genotyping by three different methods in a routine diagnostic setting.
    Padalko E; Ali-Risasi C; Mesmaekers S; Ryckaert I; Van Renterghem L; Lambein K; Bamelis M; De Mey A; Sturtewagen Y; Vastenavond H; Broeck DV; Weyers S; Praet M
    Eur J Cancer Prev; 2015 Sep; 24(5):447-53. PubMed ID: 25370681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay.
    Cho HW; Ouh YT; Hong JH; Min KJ; So KA; Kim TJ; Paik ES; Lee JW; Moon JH; Lee JK
    J Virol Methods; 2019 Jul; 269():77-82. PubMed ID: 30998958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods.
    Castro FA; Koshiol J; Quint W; Wheeler CM; Gillison ML; Vaughan LM; Kleter B; van Doorn LJ; Chaturvedi AK; Hildesheim A; Schiffman M; Wang SS; Zuna RE; Walker JL; Dunn ST; Wentzensen N
    BMC Infect Dis; 2015 Nov; 15():544. PubMed ID: 26607224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer.
    Moberg M; Gustavsson I; Gyllensten U
    J Clin Microbiol; 2003 Jul; 41(7):3221-8. PubMed ID: 12843067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
    Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human papillomavirus DNA in self-administered vaginal swabs as compared to cervical swabs.
    Palmisano ME; Gaffga AM; Daigle J; Brinkman J; Mire K; Lenczyk K; Martin DH; Hagensee ME
    Int J STD AIDS; 2003 Aug; 14(8):560-7. PubMed ID: 12935387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge.
    Geraets DT; van Baars R; Alonso I; Ordi J; Torné A; Melchers WJ; Meijer CJ; Quint WG
    J Clin Virol; 2013 Jun; 57(2):125-9. PubMed ID: 23518442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples.
    Huang SL; Chao A; Hsueh S; Chao FY; Huang CC; Yang JE; Lin CY; Yan CC; Chou HH; Huang KG; Huang HJ; Wu TI; Tseng MJ; Qiu JT; Lin CT; Chang TC; Lai CH
    J Clin Microbiol; 2006 May; 44(5):1733-9. PubMed ID: 16672400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.